India tightens rules to enforce stricter good manufacturing practices at pharma units

The Indian government has officially notified the implementation of updated Schedule M guidelines. These revised guidelines mandate stricter adherence to Good Manufacturing Practices (GMP) by pharmaceutical manufacturing units across the country.

With this revision, the emphasis is placed on enhancing and updating the existing GMP framework to align with international expectations, thereby fortifying the reputation of Indian pharmaceuticals on the global stage.